Zacks.com on MSN6mon
Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study
Shares of Aura Biosciences AURA gained 7.9% on Sept. 12 after the company announced encouraging data from a phase II study ...
Hosted on MSN8mon
Study finds how neurological symptoms associated with aura, migraine
The most widely accepted theory is that nerve endings resting on the outer surface of the membranes that enclose the brain are responsible for the headaches that follow an aura. The new study ...
Aura Intelligence Redefines the Future of AI-Driven Workforce Intelligence with a Game-Changing Platform Update
Organizational Decision Intelligence has just taken a massive leap forward. Aura Intelligence ("Aura"), the AI powerhouse ...
Investing14d
Aura Biosciences to present new bladder cancer study data
BOSTON - Aura Biosciences, Inc. (NASDAQ ... The new data stems from a study evaluating the safety and efficacy of bel-sar, a Virus-like-Drug-Conjugate (VDC), in patients with NMIBC.
The Victoria Advocate13d
Aura Intelligence Redefines the Future of AI-Driven Workforce Intelligence with a Game-Changing Platform Update
SAN FRANCISCO, March 4, 2025 /PRNewswire/ -- Organizational Decision Intelligence has just taken a massive leap forward. Aura Intelligence ("Aura"), the AI powerhouse that turns fragmented ...